BPC 157 Outperforms H2 Blockers and Dopamine Drugs for Stomach and Duodenal Ulcers
BPC 157 was the only compound that consistently protected against both gastric and duodenal ulcers across all three models, regardless of timing.
Quick Facts
What This Study Found
BPC 157 was the only tested compound that consistently protected against gastric and duodenal ulcers in all three models, regardless of whether given before, during, or after ulcer induction.
Key Numbers
How They Did This
Rats received BPC 157 (intraperitoneally or intragastrically) before, during, or after ulcer induction by 48-hour restraint stress, subcutaneous cysteamine, or intragastric 96% ethanol. Results were compared to H2 blockers, dopamine promotors, and gut peptides.
Why This Research Matters
BPC 157's consistent gut protection across multiple models and treatment timings suggests a robust protective mechanism. This study is one of the key early papers establishing BPC-157 as a gastric protective peptide.
The Bigger Picture
BPC 157's consistent gut protection regardless of timing or ulcer type sets it apart from established treatments. Its anti-inflammatory effect adds to its therapeutic potential.
What This Study Doesn't Tell Us
Animal study in rats. The ulcer models are artificial and may not fully represent human peptic ulcer disease. This study is from the lab that discovered BPC 157, and independent replication is important.
Questions This Raises
- ?What is BPC 157's mechanism for such broad gastric protection?
- ?Could BPC 157 replace or supplement current ulcer medications?
Trust & Context
- Key Stat:
- Only compound in all 3 models BPC 157 was the sole agent providing consistent gastric + duodenal protection across restraint stress, cysteamine, and ethanol models
- Evidence Grade:
- Moderate — comprehensive animal study with multiple comparator drugs and models. From the BPC 157 discovering lab; independent replication important.
- Study Age:
- Published in 1994 (32 years ago). One of the key early BPC 157 gut protection papers.
- Original Title:
- The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides.
- Published In:
- Life sciences, 54(5), PL63-8 (1994)
- Authors:
- Sikiric, P(36), Seiwerth, S(42), Grabarevic, Z(12), Petek, M, Rucman, R, Turkovic, B, Rotkvic, I, Jagic, V, Duvnjak, M, Mise, S
- Database ID:
- RPEP-00309
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How does BPC 157 protect the gut?
The exact mechanism isn't fully clear, but it appears to enhance the gut's natural protective factors, reduce inflammation, and promote tissue repair. Unlike H2 blockers that just reduce acid, BPC 157 seems to strengthen the gut's defenses.
Why is it important that it works with any timing?
Most ulcer drugs must be taken preventively. BPC 157's effectiveness whether given before, during, or after ulcer formation means it could treat existing ulcers as well as prevent new ones.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00309APA
Sikiric, P; Seiwerth, S; Grabarevic, Z; Petek, M; Rucman, R; Turkovic, B; Rotkvic, I; Jagic, V; Duvnjak, M; Mise, S. (1994). The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides.. Life sciences, 54(5), PL63-8.
MLA
Sikiric, P, et al. "The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides.." Life sciences, 1994.
RethinkPeptides
RethinkPeptides Research Database. "The beneficial effect of BPC 157, a 15 amino acid peptide BP..." RPEP-00309. Retrieved from https://rethinkpeptides.com/research/sikiric-1994-the-beneficial-effect-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.